Visikol, a biotechnology firm, announced on Thursday it has expanded its headquarters and moved to a 6,400-square-foot space in Hampton.
The new 228,000-square-foot Class A facility, located in the Perryville III building, is split evenly between office and lab space to house the 16-person Visikol team. Within the space, there are dedicated areas for advanced imaging, computing, cell culture, histopathology and general lab work.
“Initially, when we launched the company we decided to stay in New Jersey and build the company out of the NJ EDA CCIT incubator simply out of convenience as it was a few hundred feet away from our labs at Rutgers. However, as we have grown, we have really enjoyed building our business in New Jersey and have found it to be a great location for being close enough to Clients but also affordable wherein we can provide our Clients best-in-class services at an attractive price point,” described Visikol CEO Dr. Michael Johnson. Over the next few years, Visikol will use this new facility as a springboard to expand its services through continual R&D as well as to execute Client projects through the companies current service offering.
More from ROI-NJ on Visikol:
- Biotech has found extra help: High school students
